CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration

• Tilo W. Eichler ,

  * E-mail: tilo.eichler@helse-bergen.no

  Affiliation Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯
• Cecilie Totland,

  Affiliation Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯
• Mette Haugen,

  Affiliation Department of Neurology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Tor H. Qvale,

  Affiliation Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯
• Kibret Mazengia,

  Affiliation Department of Clinical Medicine, University of Bergen, Bergen, Norway

  ⨯
• Anette Storstein,

  Affiliation Department of Neurology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Bjørn I. Haukanes,

  Affiliation Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway

  ⨯
• Christian A. Vedeler

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Neurology, Haukeland University Hospital, Bergen, Norway

  ⨯